We initially evaluated the expression of p73 protein in a panel of normal (MCF10A), DCIS (MCF10A_DCIS), ER+ invasive breast cancer (MCF-7, T47D), and triple-negative (MDA-MB-231) breast cancer cell lines. Here, TP73 is linked to ductal breast carcinoma in situ.